Skip to main navigationSkip to main content
The University of Southampton
Medicine

Our impact

We have an outstanding reputation and are committed to the pursuit of excellence in biomedical sciences and clinical research. In the 2014 REF, 94% of the Faculty's research was rated 3 or 4* for impact. Our vision is to translate biomedical research into clinical outcomes that improve health worldwide. Below we feature just some examples of the ways that our research is impacting on lives of people in UK, and all over the world.

Osteoporotic fractures
Reducing the burden of osteoporotic fractures in older age

A lifecourse approach to reducing the burden of osteoporotic fractures

Research at the MRC Lifecourse Epidemiology Unit has improved bone density in younger people and reduced osteoporosis and fracture rates in older age.

Read more
According to Asthma UK 5.2 million people receive treatment for asthma with 500,000 suffering severe symptoms
Targeting the causes of respiratory disease

Agile drug development and point of care testing for diagnosis and treatment of asthma, COPD and COVID-19

Southampton scientists have developed, trialled and commercialised a successful therapy for virus-induced inflammatory lung conditions including asthma, chronic obstructive pulmonary disease and COVID-19.

A point of care test developed in Southampton for the trials, provides COVID-19 test results in one hour – a dramatic reduction from one day.

Read more
Antimicrobial stewardship
Antimicrobial stewardship

Antimicrobial stewardship: targeting antibiotics, delayed prescribing, and communication skills training for respiratory tract infections

Our longstanding research in antibiotic prescribing has made major contributions to the global fight against antimicrobial resistance.

Read more
Cancers of the gastrointestinal tract
Changed clinical practice for cancers of the gastrointestinal tract

Changing treatment paradigms in gastrointestinal cancers

Our research has defined new standards of care and changed clinical practice for cancers of the gastrointestinal tract worldwide.

Read more
Globally, leukaemia accounts for some 300,000 new cases each year with 222,000 deaths
Monoclonal Antibody cancer treatment

Delivering clinical and commercial impact through novel monoclonal antibody cancer treatments

We have helped develop the next generation of cancer drugs based on monoclonal antibodies, leading to improved treatment for millions of patients and substantial economic benefit.

Read more
Baby with thermometer
An early diagnosis can mitigate these problems through appropriate treatment and surveillance

Discovering, diagnosing and treating imprinting disorders

Our research in medical epigenetics has changed the way imprinted disorders are diagnosed and treated, improving the lives of patients around the world.

Read more
POWEr
POWEr

POWeR - cost effective online support for weight management

Our multidisciplinary research has resulted in the development of ‘POWeR’ – Positive Online Weight Reduction – a self-guided digital intervention to initiate and sustain weight loss and physical activity. POWeR has been taken up by local health authorities, making it available to millions.

Read more
Children doing exercises
Changes in diet and lifestyle

Preventing transmission of non-communicable disease risk across generations

We have made key discoveries demonstrating that the diet and lifestyle of prospective parents and pregnant mothers can have a critical impact on the long-term health of their children, and that such impacts can be mitigated by changes in diet and lifestyle.

Read more
Professor Stephen Holgate
Professor Stephen Holgate

The health effects of air pollution: Driving policy and legislative change to improve air quality and protect public health

Our longstanding body of respiratory research has led to significant changes in government legislation, national and regional policy, and public awareness of the health effects of air pollution.

Read more
Stem cell research
Our stem cell research has led to the use of novel biomaterial scaffolds in the treatment of bone damage and disease

Therapeutic and commercial translation of skeletal stem cells for new approaches to orthopaedic treatment

Our stem cell research has led to the use of novel biomaterial scaffolds in the treatment of bone damage and disease.

Read more
PET scan of someone with lymphoma
PET scan of someone with lymphoma

Transforming standards of care and treatments for lymphoid cancers

Lymphoma and lymphocytic leukaemia are common types of malignancy, and modern treatments have resulted in steadily improving survival rates. Our research has made seminal contributions to understanding the pathogenesis, prognosis and treatment of lymphoid malignancies, with results that have been translated into direct benefit for patients.

Read more
Eye diseases
Our research has discovered a cost-effective treatment for age-related macular degeneration

Use of bevacizumab in common and rare eye diseases

Our research has discovered a cost-effective treatment for age-related macular degeneration, as well as the first ever treatment for Sorsby fundus dystrophy, a rare juvenile form of macular degeneration.

Read more
Privacy Settings